BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kowada A. Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries. Scandinavian Journal of Gastroenterology 2019;54:685-9. [DOI: 10.1080/00365521.2019.1627408] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng H, Xie Q, Zhan M, Jin C, Li Q. Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer. Patient Prefer Adherence 2021;15:77-85. [PMID: 33519193 DOI: 10.2147/PPA.S286860] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Canakis A, Pani E, Saumoy M, Shah SC. Decision model analyses of upper endoscopy for gastric cancer screening and preneoplasia surveillance: a systematic review. Therap Adv Gastroenterol 2020;13:1756284820941662. [PMID: 32728390 DOI: 10.1177/1756284820941662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
3 Kowada A. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication. Dig Dis Sci 2021. [PMID: 33417196 DOI: 10.1007/s10620-020-06813-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Huang Q, Jia X, Chu Y, Zhang X, Ye H. Helicobacter pylori Infection in Geriatric Patients: Current Situation and Treatment Regimens. Front Med (Lausanne) 2021;8:713908. [PMID: 34660627 DOI: 10.3389/fmed.2021.713908] [Reference Citation Analysis]
5 Zhang L, Liu XY, Zhong G, Xin Z, Sun XY, Wang ZY. A protocol of systematic review and meta-analysis of narrow band imaging endoscopy in detection of early gastric cancer. Medicine (Baltimore) 2020;99:e21420. [PMID: 32871989 DOI: 10.1097/MD.0000000000021420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kowada A, Asaka M. Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis. Helicobacter 2022;:e12886. [PMID: 35343031 DOI: 10.1111/hel.12886] [Reference Citation Analysis]
7 Qin S, Wang X, Li S, Tan C, Zeng X, Luo X, Yi L, Peng L, Wu M, Peng Y, Wang L, Wan X. Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study. Pharmacoeconomics 2022. [PMID: 35701687 DOI: 10.1007/s40273-022-01160-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kowada A, Asaka M. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis. Helicobacter 2021;:e12837. [PMID: 34278663 DOI: 10.1111/hel.12837] [Reference Citation Analysis]
9 Wang Z, Han W, Xue F, Zhao Y, Wu P, Chen Y, Yang C, Gu W, Jiang J. Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation. Gut 2022:gutjnl-2021-325948. [PMID: 35902213 DOI: 10.1136/gutjnl-2021-325948] [Reference Citation Analysis]